Stanford Cancer Center - Palo Alto — Stanford, California

Stanford Cancer Center - Palo Alto is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Cancer Center - Palo Alto has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF).

Sponsors: Kartos Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Center - Palo Alto?

Stanford Cancer Center - Palo Alto has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Center - Palo Alto conducted?

Stanford Cancer Center - Palo Alto has 1 clinical trials on record. Their work covers Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF).

Is Stanford Cancer Center - Palo Alto accredited by Crixeo Health?

Stanford Cancer Center - Palo Alto has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Center - Palo Alto?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.